This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Pharmaceutical Research and Manufacturers of America files motion for summary judgment, says FTC lacks authority to target specific industries

( February 7, 2014, 23:31 GMT | Official Statement) -- MLex Summary: Pharmaceutical Research and Manufacturers of America has filed a motion for summary judgment in its favor concerning its case challenging the US Federal Trade Commission rule requiring pharmaceutical companies to report certain licensing transactions. PhRMA argues that Congress has intentionally withheld from the FTC the authority to make rules targeting certain industries and that the FTC failed to provide an adequate basis for its decision. See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login